Exploring the complex relations between inflammation and aging (inflamm-aging): Anti-inflamm-aging remodelling of inflamm- aging, from robustness to frailty

Inflammation Research

Volumn 57, Issue 12, 2008, Pages 558-563

  Sergio, G ^a  

^a INRCA   (Italy)

Author keywords

Cortisol and aging; Dehydroepiandrosterone (DHEA); Hypothalamo pituitary adrenocortical (HPA) axis; Inflammaging; Oxidative stress and aging

Indexed keywords

CYTOKINE; HYDROCORTISONE; PRASTERONE;

AGING; CYTOKINE RELEASE; FRAIL ELDERLY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; INFLAMMAGING; INFLAMMATION; NOTE; PATHOPHYSIOLOGY; SENESCENCE;

AGING; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY, INNATE; INFLAMMATION; PITUITARY-ADRENAL SYSTEM;

EID: 58149119644     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-7243-2     Document Type: Note

References (43)

1. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottavini E. De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000 ;908: 244-54.
2. Salvioli, S., Capri, M., Valensin, S., Tieri, P., Monti, D., Ottaviani, E., Franceschi, C.. Inflamm-Aging, Cytokines and Aging: State of the Art, New Hypotheses on the Role of Mitochondria and New Perspectives from Systems Biology. Current Pharmaceutical Design 2006; 12 (24): 3161-71.
3. Salvioli S., Capri M., Valensin S., Tieri P., Monti D., Ottavini E., Franceschi C. Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr.Pharm.Des. 2006; 12 (24): 3161-71.
4. De Martinis M., Franceschi C., Monti D., Ginaldi L.. Inflammaging and lifelong antigenic load as major determinants of aging rate and longevity. FEBS Lett. 11; 2005; 579(10): 2035-9.
5. Fagiola U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993; 23: 2375-237.
6. Franceschi C, Monti D, Sansoni P, Cossarizza A: The immunology of exceptional individuals:the lesson of centenarians. Immunol Today 1995; 16: 12-16.
7. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Marchegiceni F, Olivieri F, Franceschi C, Caruso C: Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-α -308 promoter SNP. J Med Genet 2003; 40: 296-9.
8. Turnbull, Andrew V., and Catherine L. Rivier. Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action. Physiol. Rev. 1999; 79: 1-71.
9. Cohen, M. C., And S. Cohen. Cytokine function. A study in biological diversity. Am. J. Clin. Pathol. 1996; 105: 589-98.
10. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, And A. Mantovani. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-5.
11. Banks, W. A., A. J. Kastin, And R. D. Broadwell. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995; 2: 241-8.
12. Besedovsky, H., E. Sorkin, D. Felix, And H. Haas. Hypothalamic changes during the immune response. Eur. J. Immunol. 1977; 7: 323-5.
13. Mcewan, B. S., C. A. Biron, K. W. Brunson, K. Bulloch, W. H. Chambers, F. S. Dhabhar, R. H. Goldfarb, R. P. Kitson, A. H. Miller, R. L. Spencer, And J. M. Weiss. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 1997; 23: 79-133.
14. Blalock, J. E.. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 1989; 69: 1-32.
15. Knudsen, PJ, Dinarello CA, and Strom TB. Glucocorticoids inhibit transcriptional and post transcriptional expression of interleukin-1 in U937 cells. J Immunol 1987; 139: 4129-34.
16. Lew, W, Oppenheim JJ, and Matsushima K. Analysis of the supression of IL-1 and IL-1 production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol 1988; 140: 1895-1902.
17. Mastorakos G., Ilias I., Corticotropin-releasing hormone (CRH and inflammation. Adrenal Physiology and Disease. George Chrousos Editor Endotext.com, 2003.
18. Besedovsky, H., A. Del Rey, E. Sorkin, And C. A. Dinarello. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233: 652-4.
19. Besedovsky, H. O., A. Del Rey, And E. Sorkin. Antigenic competition between horse and sheep red blood cells as hormone-dependent phenomenon. Clin. Exp. Immunol. 1979; 37: 106-13.
20. Del Rey, A., H. Besedovsky, And E. Sorkin. Endogenous blood levels of corticosterone control the immunologic cell mass and B cell activity in mice. J. Immunol. 1984; 133: 572-5.
21. Giordano R., Bo M., Pellegrino M., Vezzari M., Baldi M., Picu A., Balbo M., Bonelli L., Migliaretti G., Ghigo E., Arvat E., Hypothalamus-pituitary- adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. Journal of Clinical Endocrinology & Metabolism. 2005; 90: 5656-62.
22. Boscaro M., Paoletta,A., Scarpa,E., Barzon,L., Fusaro,P., Fallo,F., Sonino N. Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man.. Journal of Clinical Endocrinology and Metabolism 1998; 83: 1380-3.
23. Greenspan, SL, Rowe JW, Maitland LA, McAloon-Dyke M, and Elahi D..The pituitary-adrenal glucocorticoid response is altered by gender and disease. J Gerentol 1993; 3: 72-7.
24. Jane M. Daun, Richard W. Ball, and Joseph G. Cannon . Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender Am J Physiol Regul Integr Comp Physiol 2000; 278: 855-62.
25. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W, Anti-glucocorticoid effects of dehydroepiandrostenedione (DHEA). Mol. Cell Biochem. 1994; 131: 99-104.
26. May, M., E. Holmes, W. Rogers, and M. Poth. Protection from Glucocorticoid Induced Thymic Involution by Dehydroepiandrosterone. Life Sciences 1990; 46: 1627-31.
27. Wright, B. E., J. R. Porter, E. Browne, and F. Svec. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obesity 1992; 16: 579-93.
28. Araneo, B. and R. Daynes. Dehydropepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endorinology 1995; 136: 393-401. [29] Butcher SK, Killampalli V, Lashelles D, Wang K,Alpar EK, Lord JM . Raised cortisol:DHEAS ratios may contribute to reduced immunity following physical stress in the elderly. Aging Cell. 2005; 4(6): 319-24.
29. Butcher SK, Killampalli V, Lashelles D, Wang K,Alpar EK, Lord JM . Raised cortisol:DHEAS ratios may contribute to reduced immunity following physical stress in the elderly. Aging Cell. 2005; 4(6): 319-24.
30. Gupta S, Agrawal A, Agrawal S, Su H, Gollapudi S. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immunity & Aging 2006; 3,5: 1-8.
31. Smith RG, Betancourt L, Sun Y. Molecular endocrinology of the aging central nervous system. Endocrine Reviews 2005; 26(2): 203-50.
32. Wust S, Federenko IS, van Rossum EFC, Koper JW, Hellhammer DH. Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors. Psychoneuroendocrinology 2005; 30: 199-211.
33. Sterling P, Eyer J, Allostasis:a new paradigm to explain arousal pathology, in Fisher S, Reason J (Eds), Handbook of Life Stress, Cognition and Health. Wiley, New York, pp. 629-49.
34. McEwen BS, Protective and damaging effects of stress mediators. New Engl.J.Med. 1998; 338: 171-9.
35. McEwen BS, Stellar E, Stress and the individual, mechanisms leading to disease. Arch.Intern.Med. 1993; 153 (18): 2093-101.
36. Mulla A, Leroux C, Solito E, Buckingham JC . Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulate d adrenal function. J Clin Endocrinol Metab 2005; 90(1): 557-62.
37. John, C.D. & Buckingham J.C.. Cytokines: Regulation of the hypothalamo-pituitary-adrenocortical axis. Current Opinion in Pharmacology; 2003; 3: 1-7.
38. Buckingham JC; John CD; Solito E; Tierney T; Flower RJ; Christian H; Morris J.. Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci. 2006; 1088: 396-409.
39. Perretti M., Gavins F.N. Annexin 1:an endogenous anti-inflammatory protein. News Physiol. Sci. 2003; 18: 60-4.
40. Buckingham J.C. John C.D. Solito E. Tierney T. Flower R.J. Christian H., Morris J.. Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci. 2006; 1088: 396-409.
41. Trougakos I.P., Saridaki A., Panayotou G. , Gonos E.S.. Identification of differentially expressed proteins in senescent human embryonic fibroblasts. Mechanism of Aging and Development 2006; 127: 88-92.
42. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L. , Celani L., Scurti M., Ceveni E., Castellani G.C., Salvioli S.. Inflammaging : A systemic perspective on aging and longevity emerged from studies in humans. Mechanism of Aging and Development 2007; 128: 92-105.
43. Kitano H., Oda K.,Kimura T., Matsuoka Y., Csete M., Doyle J., Muramatsu M.. Metabolic Syndrome and Robustness Tradeoffs Diabetes 2004; 53: 6-15.